Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Physical activity assessment in cystic fibrosis: A position statement.
Bradley J, O'Neill B, Kent L, Hulzebos EH, Arets B, Hebestreit H; Exercise Working Group European CF Society, for publication in Journal of CF; Exercise Working Group European CF Society. Bradley J, et al. Among authors: arets b. J Cyst Fibros. 2015 Nov;14(6):e25-32. doi: 10.1016/j.jcf.2015.05.011. Epub 2015 Jul 26. J Cyst Fibros. 2015. PMID: 26219990 Free article. Review.
Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.
Kristensen M, Prevaes SMPJ, Kalkman G, Tramper-Stranders GA, Hasrat R, de Winter-de Groot KM, Janssens HM, Tiddens HA, van Westreenen M, Sanders EAM, Arets B, Keijser B, van der Ent CK, Bogaert D. Kristensen M, et al. Among authors: arets b. J Cyst Fibros. 2020 Jul;19(4):553-561. doi: 10.1016/j.jcf.2020.04.007. Epub 2020 May 30. J Cyst Fibros. 2020. PMID: 32487494 Free article.
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.
Flume PA, Biner RF, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE; VX14-661-110 study group. Flume PA, et al. Lancet Respir Med. 2021 Jul;9(7):733-746. doi: 10.1016/S2213-2600(20)30510-5. Epub 2021 Feb 10. Lancet Respir Med. 2021. PMID: 33581080
Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover study.
van Velzen AJ, Uges JWF, Heijerman HGM, Arets BGM, Nuijsink M, van der Wiel-Kooij EC, van Maarseveen EM, van Zanten GA, Pullens B, Touw DJ, Janssens HM. van Velzen AJ, et al. Among authors: arets bgm. Br J Clin Pharmacol. 2019 Sep;85(9):1984-1993. doi: 10.1111/bcp.13988. Epub 2019 Jul 10. Br J Clin Pharmacol. 2019. PMID: 31112621 Free PMC article. Clinical Trial.
Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study.
Henriette Zweijpfenning SM, Chiron R, Essink S, Schildkraut J, Akkerman OW, Aliberti S, Altenburg J, Arets B, van Braeckel E, Delaere B, Gohy S, Haarman E, Lorent N, McKew G, Morgan L, Wagner D, van Ingen J, Hoefsloot W. Henriette Zweijpfenning SM, et al. Among authors: arets b. Chest. 2022 Jul;162(1):76-81. doi: 10.1016/j.chest.2022.01.015. Epub 2022 Jan 19. Chest. 2022. PMID: 35063454 Free PMC article. No abstract available.
21 results